logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
S

Sylvie Chabaud

centre leon berard
H指数:46
被引数:1.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Influence of Adverse Pathologic Features on Potential Benefit of Hormone Therapy Use with Postoperative Radiotherapy in Recurrent Prostate Cancer: An Individual Patient Data Meta-analysis

不良病理特征对术后放疗联合激素治疗在复发性前列腺癌中潜在获益的影响：一项个体患者数据Meta分析

European Urology
IF25.2
2026-07-280
PRE
Amar U. Kishan; Yilun Sun; Christopher C. Parker; Paul Sargos; Matthew Sydes; Sylvie Chabaud; Meryem Brihoum; Stephane Supiot; Igor Latorzeff; Stephane Guerif; Tahmineh Romero Kalbasi; Michael L. Steinberg; Luca F. Valle; Kekoa Taparra; Matthew J. Farrell; Jonathan E. Shoag; Jorge A. Garcia; Jason R. Brown; Matthew B. Rettig; Adam E. Singer
Cabozantinib in Patients with Non-Locally Pretreated Brain Metastases from Renal Cell Carcinoma: Results of the Multicenter Phase II Trial CABRAMET

卡博齐坦在非局部预处理的肾细胞癌脑转移患者中的疗效：CABRAMET多中心II期试验结果

European Journal of Cancer
IF7.1
2026-04-010
PRE
Sylvie Negrier; Loïc Mourey; Cécile Dalban; Marine Gross-Goupil; Aude Fléchon; Bernard Escudier; Philippe Barthélémy; Stéphane Oudard; Emeline Colomba; Constance Thibault; Alain Ravaud; Christine Chevreau; Helen Jane Boyle; Ellen Blanc; Sylvie Chabaud; David Pérol; Laurence Albiges; Ronan Flippot
Nivolumab in combination with ipilimumab versus capecitabine as post-operative treatment for triple negative breast cancer patients with residual disease after neoadjuvant chemotherapy: a multicentre, randomized, open-label phase II trial – BREASTIMMUNE-03

纳武利尤单抗联合伊匹木单抗与卡培他滨作为新辅助化疗后仍有残留病灶的三阴性乳腺癌患者的术后治疗：一项多中心、随机、开放标签的II期试验——BREASTIMMUNE-03

The Breast
IF0
2025-11-210
OAAI
Olivier Trédan; Delphine Loirat; Sylvie Chabaud; Philippe Toussaint; Thierry Petit; Frédéric Viret; Christelle Levy; Aurélien Robert; Julien Grenier; Laura Mansi; Jean-Philippe Spano; Anne Patsouris; Olfa Derbel; Christelle Jouannaud; Jean Marc Ferrero; Jean Sébastien Frenel; Yann Molin; Louis Doublet; Pierre-Etienne Heudel; Jean-Yves Pierga
Nivolumab in Metastatic Clear-cell Renal Cell Carcinoma: An Integrative Biomarker Analysis from the NIVOREN GETUG-AFU 26 Phase 2 Study

转移性透明细胞肾细胞癌中的Nivolumab: 来自NIVOREN getug-afu 26 2期研究的综合生物标志物分析

European Urology
IF25.2
2025-11-110
PRE
Ronan Flippot; Yann-Alexandre Vano; Cécile Dalban; Benoit Beuselinck; Aude Fléchon; Maxime Meylan; Damien Pouessel; Antoine Bougoüin; Catherine Sautes-Fridman; Gwenaelle Gravis; Nathalie Chaput; Stéphane Oudard; Aude Desnoyer; Brigitte Laguerre; Salem Chouaib; Philippe Barthelemy; Delphine Borchiellini; Lucia Carril-Ajuria; Marine Gross-Goupil; Wolf-Herman Fridman; Lionnel Geoffrois; Frederic Rolland; Antoine Thiery-Vuillemin; Florence Joly; Sylvain Ladoire; Florence Tantot; Sylvie Chabaud; Bernard Escudier; Nathalie Rioux-Leclercq; Laurence Albiges
Stereotactic Intensity-modulated Radiotherapy After Radical Prostatectomy (SCIMITAR): 4-Year Outcomes of a Phase 2 Clinical Trial

立体定向调强放疗在根治性前列腺切除术后的应用（SCIMITAR）：一项II期临床试验的4年结果

European Urology
IF25.2
2025-09-300
PRE
Amar U. Kishan; Jesus E. Juarez Casillas; Paul Sargos; Tahmineh Romero Kalbasi; Sylvie Chabaud; Meryem Brihoum; Ankush Sachdeva; John N. Nikitas; T.Martin Ma; Danielle Karasik; Leslie K. Ballas; Derrick Lock; Luca Valle; Kekoa Taparra; Robert E. Reiter; Christopher Saigal; Karim Chamie; Nicholas Donin; Arnold I. Chin; Matthew Rettig; Nicholas G. Nickols; Yilun Sun; Daniel Spratt; James M. Lamb; Minsong Cao; Pascal Pommier; Michael L. Steinberg
Association Between Daily Timing of Everolimus and Survival in High-Risk HR+/HER2− Early Breast Cancer: A Sub-Analysis of the UCBG-UNIRAD Trial

依维莫司每日用药时间与高风险HR+/HER2-早期乳腺癌患者生存的关系：UCBG-UNIRAD试验的亚组分析

Clinical Pharmacology & Therapeutics
IF5.5
2025-08-240
PRE
Enora Laas; Anne-Sophie Hamy; Thomas Bachelot; Paul Gougis; Jérôme Lemonnier; Fabrice André; David Cameron; Judith Bliss; Sylvie Chabaud; Anne-Claire Hardy-Bessard; Magali Lacroix-Triki; Djelila Allouache; Marc Debled; Mario Campone; Laurence Venat-Bouvet; Paul Cottu; Mathilde Martinez; Julien Grenier; Florence Dalenc; Elise Dumas; Fabien Reyal; Bernard Asselain; Frédérique Penault-Llorca; Francis Lévi; Sylvie Giacchetti
Duration of Androgen Suppression with Postoperative Radiotherapy (DADSPORT) for Nonmetastatic Prostate Cancer: A Collaborative Systematic Review and Meta-analysis of Aggregate Data

非转移性前列腺癌术后放疗 (DADSPORT) 的雄激素抑制持续时间: 一项协作系统评价和汇总数据的荟萃分析

European Urology
IF25.2
2025-06-260
OAAI
Sarah Burdett; David J. Fisher; Jayne F. Tierney; Adrian D. Cook; Daniel E. Spratt; James J. Dignam; Wendy F. Seiferheld; Amar U. Kishan; Yilun Sun; Sylvie Chabaud; Jason A. Efstathiou; Christopher C. Parker; Alan Pollack; Paul Sargos; Igor Latorzeff; Meryem Brihoum; Charles N. Catton; Noel W. Clarke; Felix Y. Feng; Theodore G. Karrison; Pascal Pommier; Howard M. Sandler; Matthew R. Sydes; Claire L. Vale
Association between drug-related cutaneous adverse events and survival outcomes in patients treated with enfortumab vedotin

接受恩沃利单抗 vedotin 治疗的患者中，药物相关皮肤不良事件与生存结局的关联。

EUROPEAN JOURNAL OF CANCER
IF7.1
2025-06-010
OAAI
Belkaid, Samy; Ribereau-Gayon, Emmanuel; Chabaud, Sylvie; Anriot, Julien; Chalas, Thibald; Flechon, Aude; Boyle, Helen; Vinceneux, Armelle; Berard, Frederic; You, Benoit; Freyer, Gilles; Darnis, Sophie; Tartas, Sophie; Amini-Adle, Mona
COREGO: drug–drug interaction analysis on the efficacy and safety of regorafenib in patients with a sarcoma: pooled analysis of the data from the REGOSARC and REGOBONE trials

COREGO：regorafenib在软组织肉瘤患者中的药物相互作用对疗效和安全性的影响：REGOSARC和REGOBONE试验数据的合并分析

ESMO Open
IF8.3
2025-06-010
PRE
F. Rethouze; S. Risbourg; C. Schiffler; S. Chabaud; A. de Courrèges; M.-C. Le Deley; J.Y. Blay; F. Feutry; M. Jimenez; M. Vanseymortier; N. Penel; F. Duffaud; L. Lebellec
Twenty-year survival of advanced gastrointestinal stromal tumours treated with imatinib: exploratory long-term follow-up of the BFR14 trial

接受伊马替尼治疗的晚期胃肠道间质瘤的二十年生存率：BFR14试验的探索性长期随访

Annals of Oncology
IF65.4
2025-05-280
OAAI
J.-Y. Blay; Q. Devin; M. Toulmonde; A. Dufresne; N. Penel; A. Adenis; M. Rios; F. Bertucci; F. Duffaud; N. Firmin; T. Valentin; E. Bompas; O. Collard; M. Pracht; A. Hervieu; B. Verret; I. Ray-Coquard; P. Cassier; C. Henon; D. Perol; A. Italiano; S. Chabaud; A. Le Cesne
A randomized study of 6 versus 3 years of adjuvant imatinib in patients with localized GIST at high risk of relapse

6年与3年伊马替尼辅助治疗局部GIST复发风险高的患者的随机研究

ANNALS OF ONCOLOGY
IF65.4
2024-12-016
OAAI
Blay, J. -y.; Schiffler, C.; Bouche, O.; Brahmi, M.; Duffaud, F.; Toulmonde, M.; Landi, B.; Lahlou, W.; Pannier, D.; Bompas, E.; Bertucci, F.; Chaigneau, L.; Collard, O.; Pracht, M.; Henon, C.; Ray-Coquard, I.; Armoun, K.; Salas, S.; Spalato-Ceruso, M.; Adenis, A.; Verret, B.; Penel, N.; Moreau-Bachelard, C.; Italiano, A.; Dufresne, A.; Metzger, S.; Chabaud, S.; Perol, D.; Le Cesne, A.
Trifluridine/tipiracil plus oxaliplatin ± nivolumab vs FOLFOX ± nivolumab in HER2 negative advanced oesogastric adenocarcinoma: The PRODIGE73-UCGI40-LOGICAN trial
DIGESTIVE AND LIVER DISEASE
IF3.8
2024-08-010
OAAI
Botsen, Damien; Chabaud, Sylvie; Perrier, Herve; Ammarguellat, Hanifa; Jestin-Le-Tallec, Veronique; Olesinski, Jonathan; Toullec, Clemence; Aparicio, Thomas; Ben Abdelghani, Meher; Borg, Christophe; Bouche, Olivier; Coutzac, Clelia; Devaud, Herve; Di Fiore, Frederic; Dubreuil, Olivier; Evesque, Ludovic; Huguenin, Bruno; Muller, Marie; Poureau, Pierre-Guillaume; Oularue, Emilie; Tougeron, David; Zaanan, Aziz; Ammari, Samy; Carvalho, Nicolas De Sousa; Decazes, Pierre; De La Fouchardiere, Christelle
Adrenal Metastases Are Associated with Poor Outcomes in Patients with Metastatic Clear Cell Renal Cell Carcinoma Treated with Nivolumab in the GETUG-AFU-26 NIVOREN Phase 2 Trial
EUROPEAN UROLOGY ONCOLOGY
IF9.3
2024-08-010
PRE
Billon, Emilien; Dalban, Cecile; Oudard, Stephane; Chevreau, Christine; Laguerre, Brigitte; Barthelemy, Philippe; Borchiellini, Delphine; Geoffrois, Lionnel; Negrier, Sylvie; Joly, Florence; Thiery-Vuillemin, Antoine; Gross-Goupil, Marine; Rolland, Frederic; Priou, Frank; Mahammedi, Hakim; Tantot, Florence; Escudier, Bernard; Chabaud, Sylvie; Albiges, Laurence; Gravis, Gwenaelle
Investigating the prognostic impact of NY-ESO-1 expression and HLA subtypes in metastatic synovial sarcoma
ESMO OPEN
IF8.3
2024-08-010
OAAI
Dufresne, A.; Pokras, S.; Meurgey, A.; Chabaud, S.; Toulmonde, M.; Bompas, E.; Le Cesne, A.; Robin, Y. -M; Duffaud, F.; Valentin, T.; El Zein, S.; Leroux, A.; Dubray-Longeras, P.; Firmin, N.; de Pinieux, G.; Noal, S.; Delfour, C.; Bollard, J.; Tonon, L.; Biette, A.; Gadot, N.; Attignon, V.; Jean-Denis, M.; Woessner, M.; Klohe, E.; Thayaparan, T.; Eleftheriadou, I.; Blouch, K.; Nathenson, M. J.; Blay, J. -y.

研究方向

暂未获取到该数据
J
Jean‐Yves Blay
H 指数:158论文数:2,396被引数:9.5万
D
David Pérol
H 指数:49论文数:476被引数:1.2万
O
Olivier Trédan
H 指数:55论文数:558被引数:1.7万
I
Isabelle Ray‐Coquard
H 指数:103论文数:1,069被引数:4.3万
T
Thomas Bachelot
H 指数:65论文数:556被引数:2.4万
F
Florence Duffaud
H 指数:56论文数:430被引数:1.0万
T
Thomas Bachelot
H 指数:38论文数:378被引数:6,832
I
Isabelle Treilleux
H 指数:67论文数:644被引数:2.8万
C
Christine Chevreau
H 指数:72论文数:494被引数:2.8万
F
François Bertucci
H 指数:95论文数:1,366被引数:3.3万